The proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis

Proteome profiling is a technically complex and financially demanding field of research; as a result, both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise

Roots Analysis has announced the addition of “Proteome Profiling Services Market, 2020-2030” report to its list of offerings. 

With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis. 

To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this link

Key Market Insights

More than 210 players presently claim to offer a variety of services for proteome profiling
Majority of the service providers offer protein identification (99%) and protein quantification (82%) services. Based on application area, most of the players claim to provide services for drug development (over 75%); followed by those offering proteome profiling for disease diagnosis (39%).

Over 80% proteome profiling service providers are based in North America and Europe 
Within North America, majority (91%) of the players are headquartered in the US, whereas, in Europe, most of the companies are based in (in decreasing order of number of service providers) Germany (6), UK (2), Switzerland (2) and Sweden (2). 

Partnership activity within this domain has grown at a CAGR of 38%, between 2014 and 2019
Maximum number of partnerships were observed in 2019. Further, majority of the agreements signed with this domain were reported to be service alliances and technology licensing agreements, representing over 55% of the total instances.

North America and Europe are anticipated to capture over 70% of the overall market share by 2030
In the long term, the market in Asia Pacific is expected to grow at a relatively faster pace. Further, in terms of type of sponsor, pharmaceutical companies represent the highest share and this trend is unlikely to change in the foreseen future. 

To request a sample copy / brochure of this report, please visit this link

Key Questions Answered

• Who are the leading proteome profiling service providers?
• What are the key challenges faced by proteome profiling service providers?
• What kind of partnership models are most commonly adopted by industry stakeholders?
• What are the key performance indicators used by sponsors to evaluate potential service providers?
• How is the recent COVID-19 pandemic likely to impact the demand for proteome profiling services?
• What factors are anticipated to influence the evolution of the proteome profiling market?
• How is the current and future opportunity likely to be distributed across key market segments?

The USD 16 billion (by 2030) financial opportunity within the proteome profiling services market has been analyzed across the following segments:

• Application Area
  • Drug Discovery
  • Disease Diagnosis
  • Others
• Type of Sponsor(s)
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Research and Academic Institutes
• Key Geographical Regions 
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The report features inputs from eminent industry stakeholders, according to whom, in terms of application area, the market for proteome profiling services intended for disease diagnosis is likely to grow at a relatively faster pace. The report includes detailed transcripts of discussions held with the following experts:

• James Fedrick (President and Chief Executive Officer, Rockland Immunochemicals) 
• Anton Iliuk (Chief Technology Officer, Tymora Analytical Operations)

The research covers profiles of key players (listed below) offering proteome profiling services; each profile features an overview of the company, its service portfolio, details on proteome profiling-related services and technologies offered, recent developments, and an informed future outlook. 

• Biognosys
• BGI
• Bioproximity
• Cell Signaling Technology
• Creative Biolabs
• Creative Proteomics
• Cytomics
• i-DNA Biotechnology
• NMI TT Pharmaservices
• Poochon Scientific
• Proteomics International
• Proteome Factory
• Sciomics
• tebu-bio
• VProteomics

For additional details, please visit 
https://www.rootsanalysis.com/reports/proteome-profiling-services.html

or email sales@rootsanalysis.com

You may also be interested in the following titles: 

1. Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030
2. Peptide Therapeutics: Contract API Manufacturing Market, 2020 - 2030
3. Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com